DocGo Inc. (NASDAQ:DCGO) Given Average Rating of “Hold” by Brokerages
by Scott Moore · The Cerbat GemDocGo Inc. (NASDAQ:DCGO – Get Free Report) has been given an average rating of “Hold” by the seven research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $2.3750.
DCGO has been the topic of several research reports. Cantor Fitzgerald restated an “overweight” rating and set a $3.00 price target on shares of DocGo in a research note on Tuesday, March 17th. Stifel Nicolaus lowered their price objective on shares of DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a research note on Tuesday, March 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DocGo in a report on Monday, December 29th. Needham & Company LLC reissued a “buy” rating and set a $3.00 target price on shares of DocGo in a research report on Tuesday, March 17th. Finally, Canaccord Genuity Group reduced their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 25th.
Check Out Our Latest Research Report on DCGO
DocGo Price Performance
NASDAQ DCGO opened at $0.57 on Friday. The company has a fifty day moving average of $0.70 and a two-hundred day moving average of $0.95. The firm has a market capitalization of $56.29 million, a price-to-earnings ratio of -0.31 and a beta of 0.98. DocGo has a 52 week low of $0.55 and a 52 week high of $2.65.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC raised its position in shares of DocGo by 219.1% in the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock worth $1,258,000 after acquiring an additional 327,269 shares in the last quarter. Jane Street Group LLC raised its stake in shares of DocGo by 18.8% during the 1st quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock worth $226,000 after acquiring an additional 13,505 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in DocGo during the first quarter valued at approximately $338,000. Strs Ohio purchased a new stake in DocGo during the first quarter valued at approximately $76,000. Finally, JPMorgan Chase & Co. boosted its stake in DocGo by 16.8% in the second quarter. JPMorgan Chase & Co. now owns 290,354 shares of the company’s stock valued at $456,000 after acquiring an additional 41,679 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.